OJOG  Vol.3 No.2 , March 2013
TNF system in eutopic endometrium from women with endometriosis
ABSTRACT

The role of the tumor necrosis factor (TNF) system in endometriosis is not completely clear and therefore was the focus of this study. In eutopic endometria obtained from women with (n = 41) and without (controls; n = 34) endometriosis during laparoscopy, the subcellular location and the percentages for TNF, TNFR1, TNFR2 and CD45 positive-cells were determined (immunohistochemistry); the protein concentration (ELISA) of the soluble receptors (sTNFR1 and sTNFR2) were measured in 4h-explants culture media and the TNF concentration was performed in ex vivo endometrial homogenates. The TNF, TNFR1 and TNFR2 mRNAs were analyzed by real-time PCR. In control endometria, TNF, TNFR1 and sTNFR1 proteins increased during the late secretory phase. In endometriosis endometria, the protein highest level of TNFR1 was reached during the early and the mid secretory phases and of sTNFR1 concentration during the proliferative phase; however, during the late secretory phase, both TNFR1 and sTNFR1 protein levels were reduced compared to the control endometria (p < 0.05). TNFR2 was scarcely immunodetected in some CD45-positive stromal cells. The TNF- and CD45-positive cell percentages, the TNF and sTNFR2 concentrations, and TNF and TNFR2 mRNAs were similar in control and endometriosis endometria. Although TNFR1 mRNA was highly expressed, no significant differences were found between control and endometriosis endometria. In summary, this study establishes that TNF and TNFR1 protein expressions and the sTNFR concentrations in eutopic endometria from women with and without endometriosis are dependent on the menstrual cycle. The differences on the TNFR1 and sTNFR1 protein pattern between both groups, mainly during the mid and late secretory phases may play a role in the lower implantation rates observed in women with endometriosis, and also could be related to the altered cell death, which favor the augmented cell viability facilitating the characteristic endometrial implantation and growth outside the uterus in this disease.



Cite this paper
Boric, M. , Torres, M. , Pinto, C. , Pino, M. , Hidalgo, P. , Gabler, F. , Fuentes, A. and Johnson, M. (2013) TNF system in eutopic endometrium from women with endometriosis. Open Journal of Obstetrics and Gynecology, 3, 271-278. doi: 10.4236/ojog.2013.32051.
References
[1]   Roberts, M., Luo, X. and Chegini, N. (2005) Differential regulation of interleukins IL-13 and IL-15 by ovarian steroids, TNF-α and TGF-β in human endometrial epithelial and stromal cells. Molecular Human Reproduction, 11, 751-760.

[2]   Giudice, L.C. and Kao, L.C. (2004) Endometriosis. Lan cet, 364, 1789-1799. doi:10.1016/S0140-6736(04)17403-5

[3]   Meresman, G.F., Vighi, S., Buquet, R.A., Contreras-Ortiz, O., Tesone, M. and Rumi, L.S. (2000) Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertility & Sterility, 74, 760- 766. doi:10.1016/S0015-0282(00)01522-3

[4]   Johnson, M.C., Torres, M., Alves, A., Bacallao, K., Fuentes, A., Vega, M., et al. (2005) Augmented cell survival in eutopic endometrium from women with endometriosis: Expression of c-myc, TGF-beta1 and bax genes. Reproductive Biology Endocrinology, 3, 45-52. doi:10.1186/1477-7827-3-45

[5]   Kyama, C.M., Debrock, S., Mwenda, J.M. and D’Hooghe, T.M. (2003) Potential involvement of the immune system in the development of endometriosis. Reproductive Biology and Endocrinology, 1, 123. doi:10.1186/1477-7827-1-123

[6]   Yamauchi, N., Harada, T., Taniguchi, F., Yoshida, S., Iwabe, T. and Terakawa, N. (2004) Tumor necrosis factor-alpha induced the release of interleukin-6 from endometriotic stromal cells by the nuclear factor-kappaB and mitogen-activated protein kinase pathways. Fertility & Sterility, 82, 1023-1028. doi:10.1016/j.fertnstert.2004.02.134

[7]   Haider, S. and Knofler, M. (2009) Human tumor nerosis factor: Physiological and pathological roles in placenta and endometrium. Placenta, 30, 111-123. doi:10.1016/j.placenta.2008.10.012

[8]   Hunt, J.S., Chen, H.L. and Miller, L. (1996) Tumor necrosis factors: Pivotal components of pregnancy. Biology of Reproduction, 54, 554-562. doi:10.1095/biolreprod54.3.554

[9]   Tabibzadeh, S., Satyaswaroop, P.G., von Wolff, M. and Strwitzki, T. (1999) Regulation of TNF-α mRNA expression in endometrial cells by TNF-α and by oestradiol withdrawal. Molecular Human Reproduction, 5, 1141- 1149. doi:10.1093/molehr/5.12.1141

[10]   Von Wolff, M., Thaler, C.J., Strowitzki, T., Broome, J., Stolz, W. and Tabibzadeh, S. (2000) Regulated expression of cytokines in human endometrium throughout the menstrual cycle: Dysregulation in habitual abort. Molecular Human Reproduction, 6, 627-634. doi:10.1093/molehr/6.7.627

[11]   Mohan, M.J., Seaton, T., Mitchell, J., Howe, A., Black-burn, K., Burkhart, W., et al. (2002) The tumor necrosis factor-alpha converting enzyme (ADAM17): A unique metalloproteinase with highly defined substrate selectivity. Biochemistry, 41, 9462-9469. doi:10.1021/bi0260132

[12]   Zheng, Y., Saftig, P., Hartmann, D. and Blobel, C. (2004) Evaluation of the contribution of different ADAMs to tumor necrosis factor α (TNF α) shedding and of the function of the TNFalpha ectodomain in ensuring selective stimulated shedding by the TNF α convertase (ADAM17/ ADAM17). Journal of Biological Chemistry, 279, 42898- 42906. doi:10.1074/jbc.M403193200

[13]   Brockhaus, M., Schoenfeld, H.J., Schlaeger, E.J., Hunziker, W., Lesslauer, W. and Loetscher, H. (1990) Identification of two types of tumor necrosis factor receptors on human cell lines by monoclonal antibodies. Proceedings of the National Academy of Sciences of the United States of America, 87, 3127-3131. doi:10.1073/pnas.87.8.3127

[14]   Grell, M., Douni, E., Wajant, H., Lohden, M., Clauss, M., Maxeiner, B., et al. (1995) The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell, 83, 793-802. doi:10.1016/0092-8674(95)90192-2

[15]   Higuchi, M. and Aggarwal, B.B. (1994) TNF induces internalization of the p60 receptor and shedding of the p80 receptor. Journal of Immunology, 152, 3550-3558.

[16]   Hunt, J.S., Chen, H.L., Hu, X.L. and Tabibzadeh, S. (1992) Tumor necrosis factor-alpha messenger ribonucleic acid and protein in human endometrium. Biology of Reproduction, 47, 141-147. doi:10.1095/biolreprod47.1.141

[17]   von Wolff, M., Classen-Linke, I., Heid, D., Krusche, C.A., Beier-Hellwig, K., Karl, C., et al. (1999) Tumor necrosis factor-alpha (TNF-alpha) in human endometrium and uterine secretion: An evaluation by immunohistochemistry, ELISA and semiquantitative RT-PCR. Molecular Human Reproduction, 5, 146-152. doi:10.1093/molehr/5.2.146

[18]   Koga, K., Osuga, Y., Tsutsumi, O., Okagaki, R., Momoeda, M., Yano, T., et al. (2000) Increased concentrations of soluble tumor necrosis factor receptor (sTNFR) I and II in peritoneal fluid from women with endometriosis. Molecular Human Reproduction, 6, 929-933. doi:10.1093/molehr/6.10.929

[19]   Pino, M., Galleguillos, C., Torres, M., Sovino, H., Fuentes, A., Boric, M.A., et al. (2009) Association between MMP1 and MMP9 activities and ICAM1 cleavage induced by TNF in stromal cell cultures from eutopic endometria of women with endometriosis. Reproduction, 138, 837-847. doi:10.1530/REP-09-0196

[20]   Ponce, C., Torres, M., Galleguillos, C., Sovino, H., Boric, M.A., Fuentes, A., et al. (2009) Nuclear factor kappaB pathway and interleukin-6 are affected in eutopic endometrium of women with endometriosis. Reproduction, 137, 727-737.

[21]   Jokhi, P.P., King, A. and Loke, Y.W. (1994) Cytokine production and cytokine receptor expression by cells of the human first trimester placental-uterine interface. Cytokine, 9, 126-137. doi:10.1006/cyto.1996.0146

[22]   Otterson, M.F., Nie, L., Schmidt, J.L., Link, B. J., Jovanovic, N., Lyros, O., et al. (2012) EUK-207 protects human intestinal microvascular endothelial cells (HIMEC) against irradiation-induced apoptosis through the Bcl2 pathway. Life Sciences, 91, 771-782. doi:10.1016/j.lfs.2012.08.018

[23]   Kharfi, A., Labelle, Y., Mailloux, J. and Akoum, A. (2003) Deficient expression of tumor necrosis factor receptor type 2 in the endometrium of women with endometriosis. American Journal of Reproductive Immunology, 50, 33-40. doi:10.1016/j.cyto.2009.11.022

[24]   Tartaglia, L.A., Pennica, D. and Goeddel, D.V. (1993) Ligand passing: The 75-kDa tumor necrosis factor (TNF) receptor recruits TNF for signalling by the 55-kDa TNF receptor. The Journal of Biological Chemistry, 268, 18542- 18548.

[25]   Shibata, H., Abe, Y., Yoshioka Y., Nomura, T., Sato, M., Kayamuro, H., et al. (2010) Generation of mouse macrophages expressing membrane-bound TNF variants with selectivity for TNFR1 or TNFR2. Cytokine, 50. 75-83.

[26]   Herington, J.L., Bruner-Tran, K.L., Lucas, J.A. and Osteen, K.O. (2011) Immune interactions in endometriosis. Expert Review of Clinical Immunology, 7, 611-626. doi:10.1586/eci.11.53

[27]   Gupta, S., Goldberg, J.M., Aziz, N., Goldberg, E., Krajcir, N. and Agarwal, A. (2008) Pathogenic mechanisms in endometriosis-associated infertility. Fertility and Sterility, 90, 247-257. doi:10.1016/j.fertnstert.2008.02.093

[28]   Tremellen, K.P. and Russell, P. (2012) The distribution of immune cells and macrophages in the endometrium of women with recurrent reproductive failure. II: Adenomyosis and macrophages. Journal Reproductive Immunology, 93, 58-63. doi:10.1016/j.jri.2011.12.001

[29]   Khan, K.N., Masuzaki, H., Fujishita, A., Kitajima, M., Sekine, I. and Ishimaru, T. (2004) Differential macrophage infiltration in early and advanced endometriosis and adjacent peritoneum. Fertility and Sterility, 81, 652- 661. doi:10.1016/j.fertnstert.2003.07.037

[30]   Berbic, M., Schulke, L., Markham, R., Tokushige, N., Russell, P. and Fraser, I.S. (2009) Macrophage expression in endometrium of women with and without endometriosis. Human Reproduction, 24, 325-332. doi:10.1093/humrep/den393

[31]   Aderka, D., Engelmann, H., Maor, Y., Brakebusch, C. and Wallach, D. (1992) Stabilization of the bioactivity of tumor necrosis factor by its soluble receptors. Journal Experimental Medicine, 175, 323-329. doi:10.1084/jem.175.2.323

[32]   Rojas-Cartagena, C., Appleyard, C.B., Santiago, O.I. and Flores, I. (2005) Experimental intestinal endometriosis is characterized by increased levels of soluble TNFR2 and downregulation of TNFR1 and TNFR2 gene expression. Biology of Reproduction, 73, 1211-1218. doi:10.1095/biolreprod.105.044131

[33]   Van Zee, K.J., Kohno, T., Fischer, E., Rock, C.S., Moldawer, L.L. and Lowry, S.F. (1992) Tumor necrosis factor soluble receptors circulate during experimental and clinical inflammation and can protect against excessive tumor necrosis factor alpha in vitro and in vivo. Proceedings of the National Academy of Sciences of the United States of America, 89, 4845-4849. doi:10.1073/pnas.89.11.4845

[34]   Backonja, M.M., Coe, C.L., Muller, D.A. and Schell, K. (2008) Altered cytokine levels in the blood and cerebrospinal fluid of chronic pain patients. Journal Neuroimmunology, 195, 157-163. doi:10.1016/j.jneuroim.2008.01.005

[35]   Altan, Z.M., Denis, D., Kagan, D., Grund, E.M., Palmer, S.S. and Nataraja, S.G. (2010) A long-acting tumor necrosis factor α-binding protein demonstrates activity in both in vitro and in vivo models of endometriosis. Journal of Pharmacology and Experimental Therapeutics, 334, 460-466. doi:10.1124/jpet.110.166488

[36]   D’Hooghe, T.M., Nugent, N.P., Cuneo, S., Chai, D.C., Deer, F., Debrock, S., et al., (2006) Recombinant human TNFR1 (r-hTBP1) inhibits the development of endometriosis in baboons: a prospective, randomized, placebo- and drug-controlled study. Biology of Reproduction, 74, 131-136.

 
 
Top